Media centre
Press releases 2006
United KingdomAlmus announces Sumaptriptan off-patent launch
15 May 2006
Almus Pharmaceuticals announces the off-patent launch of Sumaptriptan 50mg and 100mg on 15 May 2006. Almus Sumatriptan offers pharmacists and patients a unique patient safety benefit as the only off-patent product to feature individual tablets and markings identified with full colour illustrations on each pack.
"Sumatriptan is part of a significant new development phase for Almus Pharmaceuticals. With the recent launch of several new and high profile products including Omeprazole and Diclofenac as well as this off-patent launch, Almus continues to demonstrate fundemental growth in its range and to lead the generics market with a superior patient safe pack design", commented Tony Foreman, Group Director of Commercial Activities, Alliance UniChem and CEO of Almus Pharmaceuticals.
For more information on Sumatriptan, the Almus range or to receive a copy of the new Almus product guide, please call: 0800 633 5950.